Results 71 to 80 of about 118,029,410 (206)

Expression of p53 oncoprotein in human ductal breast carcinoma (in situ, invasive and metastatic) [PDF]

open access: yes, 2009
Breast cancer is a malignant tumor mostly disclosed in women. It has heterogeneous biological behavior - so that the knowledge of tumor markers is very important to determine its prognosis and therapy.
Imam Susilo, NIDN. 0010086503
core   +1 more source

Quantitative detection of JMJD3 and Ki-67 in invasive ductal carcinoma of breast and their relationship with molecular typing and clinicopathological features

open access: yesZhongguo aizheng zazhi, 2020
Background and purpose: The study of molecular markers for breast cancer is helpful to diagnosis of the disease and prediction of prognosis in breast cancer patients.
徐小艳   +5 more
doaj  

Ductal Carcinoma in situ: Underestimation of Percutaneous Biopsy and Positivity of Sentinel Lymph Node Biopsy in a Brazilian Public Hospital

open access: yes, 2021
Rafael da Silva Sá,1,2 Angela Flávia Logullo,3 Simone Elias,1 Gil Facina,1 Vanessa Monteiro Sanvido,1 Afonso Celso Pinto Nazário1 1Department of Gynaecology, Breast Surgery Team, Universidade Federal de São Paulo (UNIFESP), S ...
Facina G   +5 more
core  

Supplementary Data from Single-Cell Transcriptome Profiling Reveals Intratumoral Heterogeneity and Molecular Features of Ductal Carcinoma In Situ

open access: yes, 2022
Supplementary Data from Single-Cell Transcriptome Profiling Reveals Intratumoral Heterogeneity and Molecular Features of Ductal Carcinoma In ...
Momoko Tokura (14843284)   +14 more
core   +1 more source

A rare case of extensive ductal carcinoma in situ of the breast with secretory features

open access: yesRare Tumors, 2012
We report a very rare case of extensive ductal carcinoma in situ (DCIS) of the breast with secretory features in a 30-year old Japanese woman. The patient presented with a nodule in the lower inner quadrant of the left breast measuring approximately 2-3 ...
Kenichi Sugihara   +5 more
doaj   +1 more source

Will ductal carcinoma in situ defeat breast cancer screening?

open access: yes, 2009
Gøtzsche and colleagues focus on the inadequacy of patient information leaflets in the NHS breast screening programme.1The failure to disclose information on ductal carcinoma in situ has aptly been described by a patient representative as a “closely ...
JR Benson (7752260)
core  

Different distribution of breast cancer subtypes in breast ductal carcinoma in situ and ductal carcinoma in situ with microinvasion

open access: yesZhongguo aizheng zazhi, 2018
Background and purpose: Breast ductal carcinoma in situ with microinvasion (DCIS-MI) is considered to be the interim stage in the progression from breast ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC).
李 爽, 郎冠天, 余科达
doaj  

Ductal Carcinoma In Situ: A Clinical Conundrum

open access: yes, 2013
Before the advent of breast cancer screening programs, ductal carcinoma in situ (DCIS) comprised only 2% to 5% of symptomatic cancers, and presentation as a palpable mass was extremely uncommon...
John R Benson (16266674)   +1 more
core  

Variable Appearances of Ductal Carcinoma in Situ Calcifications on Digital Mammography, Synthesized Mammography, and Tomosynthesis: A Pictorial Essay

open access: yes, 2018
This pictorial essay demonstrates the variable appearances of ductal carcinoma in situ on full-field digital mammography, synthesized mammography, and digital breast tomosynthesis.
Laurie R. Margolies   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy